Psychiatric and Neurologic Medication Pipeline

Registration Options

Activity Dates: 05/10/2021 - 04/23/2024

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

As medication management experts, pharmacists must remain up-to-date by understanding newly marketed medications and those in the clinical development pipeline. To fulfill this role, pharmacists must master essential clinically relevant knowledge about each new medication’s efficacy for the tested indication, tolerability, and safety. This information includes the pharmacodynamic mechanism of action, pharmacokinetics, drug interactions, and pharmacoeconomics. Armed with this knowledge, pharmacists will be well positioned to advocate for the use of the most beneficial medication by educating patients and other key stakeholders, including prescribers. In this session, participants will learn about therapeutic advances in new and emerging psychiatric and neurologic medications and how these agents fit into current clinical practice.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

Sign in (or create a FREE account).
Register for this course.
Review the full content of the activity and reflect upon its teachings.
Complete the post-test at the end of the activity no later than the closing activity date.
Complete the evaluation at the end of the activity.
If necessary, complete the post-test retest no later than the closing activity date.
Receive a passing grade (70%).
Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

View System Requirements to Access All Session Resources

AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:

A modern web browser with JavaScript and cookies enabled: Chrome is strongly recommended, or the latest version of Firefox or Safari.
A PDF reader: Chrome built-in, Firefox built-in, Acrobat or FoxIt
An adequate device and Internet connection: Processor: Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent); Memory: 4 GB; Storage: 5 GB available; Internet speed: 4.0 Mbps (up/down)

AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.

Faculty Information

Stephen R. Saklad, PharmD, BCPP

View biographical information

Stephen R. Saklad, PharmD, BCPP
Clinical Professor and Director of Psychiatric Pharmacy, The University of Texas at Austin, College of Pharmacy, Pharmacotherapy Division and Adjoint Professor of Medicine, University of Texas Health San Antonio
San Antonio, TX

Dr. Saklad is Clinical Professor and Director of Psychiatric Pharmacy at The University of Texas at Austin, College of Pharmacy, Pharmacotherapy Division, and consultant to San Antonio State Hospital (SASH).

Dr. Saklad received his baccalaureate degree in Bacteriology from the University of California, Los Angeles, and his Pharm.D. at the University of Southern California. He completed a NIMH training fellowship at the Nebraska Psychiatric Institute. After completing his training, he joined the faculty of The University of Texas at Austin, College of Pharmacy and the clinical staff at SASH as the first clinical pharmacist employed by the Texas state hospital system.

During his over 40-year career, Dr. Saklad has provided clinical care, education, and research in a variety of settings and treatment roles at SASH. He teaches P2 & P3 students at The University of Texas about psychiatric and neurologic pharmacotherapy and is the course director for the clinical presentation skills laboratory. He precepts and mentors P3 & P4 students on experiential rotations and in several courses.

In 1988, Dr. Saklad helped to create The University of Texas at Austin College of Pharmacy’s Psychiatric Pharmacotherapy Update and has chaired the meeting since 2007. He has been an investigator on research studies. He is a consultant for several companies on research studies, psychiatric pharmacy, improving clinical care, educational activities, and treatment issues. He is an expert witness on behalf of both defendants and plaintiffs. He has authored peer-reviewed poster presentations and journal articles as well as written book chapters and edited books. He has received several awards. He is a frequently requested speaker.

Dr. Saklad helped to organize and became a founding member of College of Psychiatric and Neurologic Pharmacists (CPNP) in 1998 and the CPNP Foundation in 2012. He initiated and developed the first websites for the UT Austin College of Pharmacy in 1994, CPNP in 1997, and helped with the CPNP Foundation’s in 2015. He has served the CPNP in a number of roles including Board Member, committees, and was the Founding Senior Editor of the Mental Health Clinician. Dr. Saklad is was the Treasurer of the CPNP Foundation 2014-2019 and a current member of the CPNP Business Development Committee.

Learning Objectives

Describe the efficacy and safety data of the emerging and recently approved psychiatric and neurologic medication pipeline.
Explain appropriate monitoring requirements, patient education points, and provider education for these agents.
Discuss clinical use of new and emerging medications and where these agents fit into current clinical practice.

Continuing Education Credit and Disclosures

Activity Dates: 05/10/2021 - 04/23/2024
ACPE Contact Hours: 1
ACPE Number: 0284-0000-21-016-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPE The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

View planning committee disclosures

2021 Program Committee

Shari N. Allen, PharmD, BCPP
Assistant Professor
PCOM-SOP
Suwanee, GA
No Relevant Financial Relationships to Disclose

Jolene R. Bostwick, PharmD, BCPP, BCPS

Program Administrative Chair

Assistant Dean for Co-Curriculum and Professional Development & Clinical Professor
University of Michigan College of Pharmacy
Ann Arbor, MI
No Relevant Financial Relationships to Disclose

Bridget Bradley, PharmD, BCPP
Associate Professor
Pacific University School of Pharmacy
Hillsboro, OR
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: PSAP May 2021, Neurology and Psychiatry Book
Educational Grants, Research Grants or Contracts: NACDS Community Pharmacy Residency Grant

Lauren M. Brown, PharmD, BCPP
Clinical Pharmacy Specialist, Psychiatry
South Texas Veterans Health Care System
San Antonio, TX
No Relevant Financial Relationships to Disclose

Austin R. Campbell, PharmD, BCPP
Clinical Pharmacy Specialist - Psychiatry
University of Missouri Health Care
Columbia, MO
Financial Interests: Up To Date Contributor "Pharmacotherapy for schizophrenia: Long-acting injectable antipsychotic drugs"
Non-Financial Interests: Extension for Community Healthcare Outcomes, Show-Me ECHO Project

Chelsea N. Carr, PharmD, BCPP
Advanced Practice Pharmacist - Psychiatry
University of Maryland - Spring Grove Hospital Center
Catonsville, MD
No Relevant Financial Relationships to Disclose

Jordan Cooler, PharmD, BCPP
Clinical Assistant Professor
University of South Carolina College of Pharmacy
Columbia, SC
No Relevant Financial Relationships to Disclose

Amber R. Douglass, PharmD, BCPS, BCPP
Clinical Pharmacy Specialist - Mental Health
VA Tennessee Valley Healthcare System
Murfreesboro, TN
No Relevant Financial Relationships to Disclose

Kristen N. Gardner, PharmD, BCPP

Program Committee Chair

Clinical Pharmacy Specialist - Behavioral Health
Kaiser Permanente Colorado
Denver, CO
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Biostrategies - one time consultant re:LAIAs

Robert J. Haight, PharmD, BCPP
Clinical Pharmacist | Forensic Services
Saint Peter Regional Treatment Center (SPRTC), Minnesota Department of Human Services
Saint Peter, MN
No Relevant Financial Relationships to Disclose

Suzanne C. Harris, PharmD, BCPP
Clinical Assistant Professor/UNC Hospitals Region Experiential Director/Clinical Pharmacist Practitioner
UNC Eshelman School of Pharmacy
Chapel Hill, NC
Educational Grants, Research Grants or Contracts: North Carolina AHEC Campus Innovations Grants

Kayla D. Johnson, PharmD, BCPS, BCPP
Vanderbilt Psychiatric Hospital
Spring Hill, TN
No Relevant Financial Relationships to Disclose

Erin D. Knox, PharmD, BCPP
Pharmacy Education Specialist
UC Irvine Health
Orange, CA
No Relevant Financial Relationships to Disclose

Marketa Marvanova, PharmD, PhD, BCGP, BCPP, FASCP
Dean and Professor
University of Montana, Skaggs School of Pharmacy
Missoula, MT
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Editorial Board member: Continuum: Lifelong Learning in Neurology, consultant for Lexicomp as a clinical specialist in neurology and psychiatry
Educational Grants, Research Grants or Contracts: AACP/NABP: District V grant, Dakota Medical Foundation

Melissa Mitchell, PharmD, BCGP, BCPP, BCPS
Senior Clinical Pharmacist
RUHS MC
Moreno Valley , CA
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Neurocrine Speakers Bureau - Ingrezza, Janssen Speakers Bureau - Spravato

Thea R. Moore, PharmD, BCPP
Associate Professor
University of South Florida
Tampa, FL
Educational Grants, Research Grants or Contracts: Agency for Health Care Administration

Kristen Neumeister, PharmD, BCPP
Clinical Pharmacist- Mental Health
John Peter Smith Hospital
Fort Worth, TX
No Relevant Financial Relationships to Disclose

Melissa C. Palmer, PharmD, BCPP, BCPS
Clinical Assistant Professor
University of Missouri-Kansas City School of Pharmacy
Kansas City, MO
No Relevant Financial Relationships to Disclose

Lindsey Peters, PharmD, BCPS
Assistant Professor of Pharmacy Practice
Ohio Northern University
Ada, OH
No Relevant Financial Relationships to Disclose

Kristina Reinstatler, PharmD, BCPP, MBA
Clinical Pharmacy Specialist
UC Health University of Cincinnati Medical Center
Cincinnati, OH
No Relevant Financial Relationships to Disclose

Michael D. Shuman, PharmD, BCPP
Staff Pharmacist
Central State Hospital
Louisville, KY
No Relevant Financial Relationships to Disclose

Sheryl Thedford, PharmD, PhD, BCPS, BCPP
Clinical Psychiatric Pharmacist
University of Maryland, Spring Grove Hospital Center
Catonsville, MD
No Relevant Financial Relationships to Disclose

Taylor A. Thomas, PharmD, BCPP
Clinical Pharmacy Specialist- Mental Health
VA Northern Indiana Health Care System
Fort Wayne, IN
No Relevant Financial Relationships to Disclose

All relevant relationships have been mitigated.

View disclaimer and disclosure of off-label use

Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Presentation-Specific Disclosure: My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices:

View fair balance and integrity statement

It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.